NEUPATH HEALTH INC (NPTH.CA) Fundamental Analysis & Valuation

TSX-V:NPTH • CA64133P1009

Current stock price

0.61 CAD
-0.03 (-4.69%)
Last:

This NPTH.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. NPTH.CA Profitability Analysis

1.1 Basic Checks

  • In the past year NPTH has reported negative net income.
  • NPTH had a positive operating cash flow in the past year.
  • NPTH had negative earnings in each of the past 5 years.
  • NPTH had a positive operating cash flow in each of the past 5 years.
NPTH.CA Yearly Net Income VS EBIT VS OCF VS FCFNPTH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.59%, NPTH is doing worse than 69.23% of the companies in the same industry.
  • NPTH has a Return On Equity of -3.48%. This is in the lower half of the industry: NPTH underperforms 61.54% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.53%, NPTH is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for NPTH is below the industry average of 6.93%.
  • The 3 year average ROIC (3.14%) for NPTH is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.59%
ROE -3.48%
ROIC 4.53%
ROA(3y)-1.2%
ROA(5y)-3.82%
ROE(3y)-2.45%
ROE(5y)-7.78%
ROIC(3y)3.14%
ROIC(5y)N/A
NPTH.CA Yearly ROA, ROE, ROICNPTH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • NPTH has a worse Operating Margin (2.34%) than 61.54% of its industry peers.
  • Looking at the Gross Margin, with a value of 19.03%, NPTH is doing worse than 69.23% of the companies in the same industry.
  • NPTH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.34%
PM (TTM) N/A
GM 19.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.29%
GM growth 5Y-1.38%
NPTH.CA Yearly Profit, Operating, Gross MarginsNPTH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. NPTH.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NPTH is destroying value.
  • NPTH has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NPTH has more shares outstanding
  • The debt/assets ratio for NPTH is higher compared to a year ago.
NPTH.CA Yearly Shares OutstandingNPTH.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
NPTH.CA Yearly Total Debt VS Total AssetsNPTH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 2.10 indicates that NPTH is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • NPTH has a Altman-Z score of 2.10. This is in the better half of the industry: NPTH outperforms 76.92% of its industry peers.
  • NPTH has a debt to FCF ratio of 4.18. This is a neutral value as NPTH would need 4.18 years to pay back of all of its debts.
  • NPTH has a Debt to FCF ratio of 4.18. This is in the better half of the industry: NPTH outperforms 69.23% of its industry peers.
  • NPTH has a Debt/Equity ratio of 0.55. This is a neutral value indicating NPTH is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.55, NPTH belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.18
Altman-Z 2.1
ROIC/WACC0.64
WACC7.1%
NPTH.CA Yearly LT Debt VS Equity VS FCFNPTH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that NPTH should not have too much problems paying its short term obligations.
  • NPTH has a better Current ratio (1.09) than 84.62% of its industry peers.
  • NPTH has a Quick Ratio of 1.09. This is a normal value and indicates that NPTH is financially healthy and should not expect problems in meeting its short term obligations.
  • NPTH's Quick ratio of 1.09 is amongst the best of the industry. NPTH outperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
NPTH.CA Yearly Current Assets VS Current LiabilitesNPTH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. NPTH.CA Growth Analysis

3.1 Past

  • NPTH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.78%.
  • Looking at the last year, NPTH shows a quite strong growth in Revenue. The Revenue has grown by 19.76% in the last year.
  • Measured over the past years, NPTH shows a quite strong growth in Revenue. The Revenue has been growing by 12.85% on average per year.
EPS 1Y (TTM)-0.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.77%
Revenue 1Y (TTM)19.76%
Revenue growth 3Y11.65%
Revenue growth 5Y12.85%
Sales Q2Q%17.01%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NPTH.CA Yearly Revenue VS EstimatesNPTH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NPTH.CA Yearly EPS VS EstimatesNPTH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 0 0.02 -0.02 0.04 0.06

More info and screens

Find the best growth stocksShow best growing peers

2

4. NPTH.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • NPTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NPTH.CA Price Earnings VS Forward Price EarningsNPTH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NPTH is valued cheaper than 84.62% of the companies in the same industry.
  • NPTH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NPTH is cheaper than 76.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.91
EV/EBITDA 9.92
NPTH.CA Per share dataNPTH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NPTH.CA Dividend Analysis

5.1 Amount

  • NPTH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NPTH.CA Fundamentals: All Metrics, Ratios and Statistics

NEUPATH HEALTH INC

TSX-V:NPTH (4/17/2026, 7:00:00 PM)

0.61

-0.03 (-4.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-26
Earnings (Next)05-13
Inst Owners10.96%
Inst Owner ChangeN/A
Ins Owners2.56%
Ins Owner ChangeN/A
Market Cap34.27M
Revenue(TTM)87.19M
Net Income(TTM)-717.00K
Analysts80
Price Target0.59 (-3.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.04%
Min Revenue beat(2)-6.89%
Max Revenue beat(2)10.97%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)16%
PT rev (3m)16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF 10.91
P/OCF 8.56
P/B 1.66
P/tB N/A
EV/EBITDA 9.92
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY9.16%
OCF(TTM)0.07
OCFY11.68%
SpS1.55
BVpS0.37
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.59%
ROE -3.48%
ROCE 6.3%
ROIC 4.53%
ROICexc 5.26%
ROICexgc 22.5%
OM 2.34%
PM (TTM) N/A
GM 19.03%
FCFM 3.6%
ROA(3y)-1.2%
ROA(5y)-3.82%
ROE(3y)-2.45%
ROE(5y)-7.78%
ROIC(3y)3.14%
ROIC(5y)N/A
ROICexc(3y)3.58%
ROICexc(5y)N/A
ROICexgc(3y)29.71%
ROICexgc(5y)N/A
ROCE(3y)4.36%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.29%
GM growth 5Y-1.38%
F-Score6
Asset Turnover1.93
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.18
Debt/EBITDA 2.63
Cap/Depr 37.67%
Cap/Sales 0.99%
Interest Coverage 5.92
Cash Conversion 92.51%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 2.1
F-Score6
WACC7.1%
ROIC/WACC0.64
Cap/Depr(3y)30.83%
Cap/Depr(5y)33.71%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.76%
Revenue growth 3Y11.65%
Revenue growth 5Y12.85%
Sales Q2Q%17.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y89.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.55%
OCF growth 3Y75.7%
OCF growth 5YN/A

NEUPATH HEALTH INC / NPTH.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEUPATH HEALTH INC?

ChartMill assigns a fundamental rating of 3 / 10 to NPTH.CA.


Can you provide the valuation status for NEUPATH HEALTH INC?

ChartMill assigns a valuation rating of 2 / 10 to NEUPATH HEALTH INC (NPTH.CA). This can be considered as Overvalued.


How profitable is NEUPATH HEALTH INC (NPTH.CA) stock?

NEUPATH HEALTH INC (NPTH.CA) has a profitability rating of 2 / 10.


Can you provide the financial health for NPTH stock?

The financial health rating of NEUPATH HEALTH INC (NPTH.CA) is 5 / 10.